📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance. (2014)

First Author: Chatzigeorgiou A

Attributed to: MRC Centre for Transplantation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1073/pnas.1400419111

PubMed Identifier: 24492375

Publication URI: http://europepmc.org/abstract/MED/24492375

Type: Journal Article/Review

Volume: 111

Parent Publication: Proceedings of the National Academy of Sciences of the United States of America

Issue: 7

ISSN: 0027-8424